메뉴 건너뛰기




Volumn 16, Issue 3, 1999, Pages 434-440

In vitro and in situ permeability of a 'second generation' hydroxypyridinone oral iron chelator: Correlation with physico-chemical properties and oral activity

Author keywords

In vitro permeability; Intestinal drug transport; Iron chelator; Lipophilicity; Oral absorption; Solubility

Indexed keywords

3 HYDROXY 1 (2 HYDROXYETHYL) 2 HYDROXYPHENYLMETHYL 1H PYRIDIN 4 ONE; DEFERIPRONE; DEFEROXAMINE MESYLATE; IRON CHELATING AGENT; PYRIDONE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 0032905413     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018886005136     Document Type: Article
Times cited : (16)

References (32)
  • 2
    • 0031457203 scopus 로고    scopus 로고
    • A risk-benefit of iron-chelation therapy
    • 2. J. B. Porter. A risk-benefit of iron-chelation therapy. Drug Saf. 17:407-421 (1997).
    • (1997) Drug Saf. , vol.17 , pp. 407-421
    • Porter, J.B.1
  • 5
    • 0023700267 scopus 로고
    • Selection of hydroxypyridin-4-ones for the treatment of Iron Overload using in vitro and in vivo models
    • 5. E. R. Huehns, J. B. Porter, and R. C. Hider. Selection of Hydroxypyridin-4-ones for the treatment of Iron Overload using in vitro and in vivo models. Haemoglobin 12:593-600 (1988).
    • (1988) Haemoglobin , vol.12 , pp. 593-600
    • Huehns, E.R.1    Porter, J.B.2    Hider, R.C.3
  • 7
    • 0023099826 scopus 로고
    • Iron chelation studies using desferrioxamine and the potential oral iron chelator, 1,2,-dimethyl-3-hydroxypyrid-4-one, in normal and iron overloaded rats
    • 7. G. J. Kontoghiorghes, L. Sheppard, A. V. Hoffbrand, J. Charalamous, J. Tiperpae, and M. J. Pippard. Iron Chelation Studies using Desferrioxamine and the Potential Oral Iron Chelator, 1,2,-Dimethyl-3-hydroxypyrid-4-one, in Normal and Iron Overloaded Rats. J. Clin. Pathol. 40:404-408 (1987).
    • (1987) J. Clin. Pathol. , vol.40 , pp. 404-408
    • Kontoghiorghes, G.J.1    Sheppard, L.2    Hoffbrand, A.V.3    Charalamous, J.4    Tiperpae, J.5    Pippard, M.J.6
  • 8
    • 0025838375 scopus 로고
    • Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4-one iron chelators in overloaded and nonoverloaded mice
    • 8. J. B. Porter, K. P. Hoyes, R. D. Abeysinghe, P. N. Brooks, E. R. Huehns, and R. C. Hider. Comparison of the Subacute Toxicity and Efficacy of 3-Hydroxypyridin-4-one Iron Chelators in Overloaded and Nonoverloaded Mice. Blood 78:2727-2734 (1991).
    • (1991) Blood , vol.78 , pp. 2727-2734
    • Porter, J.B.1    Hoyes, K.P.2    Abeysinghe, R.D.3    Brooks, P.N.4    Huehns, E.R.5    Hider, R.C.6
  • 9
    • 0023214937 scopus 로고
    • 1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload
    • 9. G. J. Kontoghiorghes, M. A. Aldouri, L. Sheppard, and A. V. Hoffbrand. 1,2-Dimethyl-3-hydroxypyrid-4-one, an Orally Active Chelator for Treatment of Iron Overload. Lancet 1294 (1987).
    • (1987) Lancet , vol.1294
    • Kontoghiorghes, G.J.1    Aldouri, M.A.2    Sheppard, L.3    Hoffbrand, A.V.4
  • 11
    • 0029079707 scopus 로고
    • Results of long-term deferiprone (L1) therapy: A report by the international study group on oral iron chelators
    • 11. F. N. Al-Refaie, C. Hershko, A. V. Hoffbrand, M. Kosaryan, N. F. Olivieri, P. Tondury, and B. Wonke. Results of Long-Term Deferiprone (L1) Therapy: A Report by the International Study Group on Oral Iron Chelators. Br. J. Haematol. 91:224-229 (1995).
    • (1995) Br. J. Haematol. , vol.91 , pp. 224-229
    • Al-Refaie, F.N.1    Hershko, C.2    Hoffbrand, A.V.3    Kosaryan, M.4    Olivieri, N.F.5    Tondury, P.6    Wonke, B.7
  • 13
    • 0002614944 scopus 로고
    • Stabilities of the iron(III) chelates of 1,2-dimethyl-3-hydroxy-4-pyridinone and related ligands
    • 13. R. J. Motekaitis and A. E. Martell. Stabilities of the Iron(III) Chelates of 1,2-Dimethyl-3-hydroxy-4-pyridinone and Related Ligands. Inorg. Chim. Acta. 183:71-80 (1991).
    • (1991) Inorg. Chim. Acta. , vol.183 , pp. 71-80
    • Motekaitis, R.J.1    Martell, A.E.2
  • 14
    • 0025804183 scopus 로고
    • Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
    • 14. P. Artusson and J. Karlsson. Correlation between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cells. Biochem. Biophys. Res. Commun. 175:880-885 (1991).
    • (1991) Biochem. Biophys. Res. Commun. , vol.175 , pp. 880-885
    • Artusson, P.1    Karlsson, J.2
  • 15
    • 0023715382 scopus 로고
    • Estimating human fraction absorbed: A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds
    • 15. G. L. Amidon, P. J. Sinko, and D. Fleisher. Estimating Human Fraction Absorbed: a Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-mediated compounds. Pharm. Res. 5:651-654 (1988).
    • (1988) Pharm. Res. , vol.5 , pp. 651-654
    • Amidon, G.L.1    Sinko, P.J.2    Fleisher, D.3
  • 16
    • 0028948839 scopus 로고
    • A theoretical basis for a Biopharmaceutic Drug Classification: The correlation of in vitro Drug Product Dissolution and in vivo bioavailability
    • 16. G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in vitro Drug Product Dissolution and in vivo Bioavailability. Pharm. Res. 12:413-420 (1995).
    • (1995) Pharm. Res. , vol.12 , pp. 413-420
    • Amidon, G.L.1    Lennernäs, H.2    Shah, V.P.3    Crison, J.R.4
  • 17
    • 0026603949 scopus 로고
    • Proline uptake by Monolayers of Human Intestinal Absorptive (Caco-2) Cells in vitro
    • 17. P. L. Nicklin, W. J. Irwin, I. F. Hassan, and M. Mackay. Proline Uptake by Monolayers of Human Intestinal Absorptive (Caco-2) Cells in vitro. Biochim. Biophys. Acta. 1104:283-292 (1992).
    • (1992) Biochim. Biophys. Acta. , vol.1104 , pp. 283-292
    • Nicklin, P.L.1    Irwin, W.J.2    Hassan, I.F.3    Mackay, M.4
  • 19
    • 0023598658 scopus 로고
    • Ionisation constants by curve fitting: Determination of partition and distribution coefficients of acids and bases and their ions
    • 19. F. H. Clarke and N. M. Cahoon. Ionisation Constants by Curve Fitting: Determination of Partition and Distribution Coefficients of Acids and Bases and their Ions. J. Pharm. Sci. 76:611-620 (1987).
    • (1987) J. Pharm. Sci. , vol.76 , pp. 611-620
    • Clarke, F.H.1    Cahoon, N.M.2
  • 20
    • 0027245634 scopus 로고
    • pH-Metric logP. 2. Refinement of partition coefficients and ionisation constants of multiprotic substances
    • 20. A. Avdeef. pH-Metric logP. 2. Refinement of Partition Coefficients and Ionisation Constants of Multiprotic Substances. J. Pharm. Sci. 82:183-190 (1993).
    • (1993) J. Pharm. Sci. , vol.82 , pp. 183-190
    • Avdeef, A.1
  • 21
    • 0027071736 scopus 로고
    • pH-Metric logP. 1. Difference plots for determining ion-pair octanol-water partition coefficients of multiprotic substances
    • 21. A. Avdeef. pH-Metric logP. 1. Difference Plots for Determining Ion-Pair Octanol-Water Partition Coefficients of Multiprotic Substances. Quant. Struct.-Act. Relat. 11:510-517 (1992).
    • (1992) Quant. Struct.-Act. Relat. , vol.11 , pp. 510-517
    • Avdeef, A.1
  • 25
    • 0019124619 scopus 로고
    • A convective mass transfer model for determining intestinal wall permeabilities: Laminar flow in a circular tube
    • 25. R. L. Elliott, G. L. Amidon, and E. N. Lightfoot. A Convective Mass Transfer Model for Determining Intestinal Wall Permeabilities: laminar Flow in a Circular Tube. J. Theor. Biol. 87:757-771 (1980).
    • (1980) J. Theor. Biol. , vol.87 , pp. 757-771
    • Elliott, R.L.1    Amidon, G.L.2    Lightfoot, E.N.3
  • 27
    • 0000773829 scopus 로고
    • Intestinal absorption mechanism of three angiolensin-converting enzyme inhibitors: Quinapril, Benazepril and CGS 16617
    • 27. S. Yee and G. L. Amidon. Intestinal Absorption Mechanism of Three Angiolensin-Converting Enzyme Inhibitors: Quinapril, Benazepril and CGS 16617. Pharm. Res. 7:S155 (1990).
    • (1990) Pharm. Res. , vol.7
    • Yee, S.1    Amidon, G.L.2
  • 29
    • 0002177778 scopus 로고
    • Biopharmaceutical considerations in drug formulation design and evaluation
    • 29. S. A. Kaplan. Biopharmaceutical Considerations in Drug Formulation Design and Evaluation. Drug Metab. Rev. 1:15-33 (1972).
    • (1972) Drug Metab. Rev. , vol.1 , pp. 15-33
    • Kaplan, S.A.1
  • 30
    • 0024405310 scopus 로고
    • Preformulation study of etoposide: Identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide
    • 30. J. C. Shah, J. R. Chen, and D. Chow. Preformulation Study of Etoposide: Identification of Physicochemical Characteristics Responsible for the Low and Erratic Oral Bioavailability of Etoposide. Pharm. Res. 6:408-412 (1989).
    • (1989) Pharm. Res. , vol.6 , pp. 408-412
    • Shah, J.C.1    Chen, J.R.2    Chow, D.3
  • 31
    • 0020035215 scopus 로고
    • Perspectives in iron metabolism
    • 31. C. A. Finch and H. Hubers. Perspectives in Iron Metabolism. New Engl. J. Med. 306:1520 (1982).
    • (1982) New Engl. J. Med. , vol.306 , pp. 1520
    • Finch, C.A.1    Hubers, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.